Expresión de BRCA1 en lesiones benignas y malignas de la mama
Fernández, Ángel; Reigosa, Aldo.
Invest. clín
; 57(4): 330-351, dic. 2016. ilus, tab
Artigo em Espanhol | LILACS | ID: biblio-841124
Documentos relacionados
BRCA1 expression in benign and malignant breast lesions.
The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays.
Screening and identification of phytochemical drug molecules against mutant BRCA1 receptor of breast cancer using computational approaches.
Hybrid-seq deciphers the complex transcriptional profile of the human <i>BRCA1</i> DNA repair associated gene.
The BRCA Tumor Suppressor Network in Chromosome Damage Repair by Homologous Recombination.
DNA repair function scores for 2172 variants in the BRCA1 amino-terminus.
Estrogen and BRCA1 deficiency synergistically induce breast cancer mutation-related DNA damage.
Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for <i>BRCA1/2</i>.
Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer.